Editorial: Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy

Detalles Bibliográficos
Autores principales: Gao, Yanfeng, Yang, Xuanming, Zhang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156861/
https://www.ncbi.nlm.nih.gov/pubmed/35663988
http://dx.doi.org/10.3389/fimmu.2022.920442
_version_ 1784718526040244224
author Gao, Yanfeng
Yang, Xuanming
Zhang, Bin
author_facet Gao, Yanfeng
Yang, Xuanming
Zhang, Bin
author_sort Gao, Yanfeng
collection PubMed
description
format Online
Article
Text
id pubmed-9156861
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91568612022-06-02 Editorial: Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy Gao, Yanfeng Yang, Xuanming Zhang, Bin Front Immunol Immunology Frontiers Media S.A. 2022-05-17 /pmc/articles/PMC9156861/ /pubmed/35663988 http://dx.doi.org/10.3389/fimmu.2022.920442 Text en Copyright © 2022 Gao, Yang and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Gao, Yanfeng
Yang, Xuanming
Zhang, Bin
Editorial: Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy
title Editorial: Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy
title_full Editorial: Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy
title_fullStr Editorial: Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy
title_full_unstemmed Editorial: Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy
title_short Editorial: Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy
title_sort editorial: development and potential mechanisms of low molecular weight drugs for cancer immunotherapy
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156861/
https://www.ncbi.nlm.nih.gov/pubmed/35663988
http://dx.doi.org/10.3389/fimmu.2022.920442
work_keys_str_mv AT gaoyanfeng editorialdevelopmentandpotentialmechanismsoflowmolecularweightdrugsforcancerimmunotherapy
AT yangxuanming editorialdevelopmentandpotentialmechanismsoflowmolecularweightdrugsforcancerimmunotherapy
AT zhangbin editorialdevelopmentandpotentialmechanismsoflowmolecularweightdrugsforcancerimmunotherapy

Ejemplares similares